These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17979210)

  • 21. BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease.
    Grube E; Buellesfeld L
    Expert Rev Med Devices; 2006 Nov; 3(6):731-41. PubMed ID: 17280537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nontoxic additive to introduce x-ray contrast into poly(lactic acid). Implications for transient medical implants such as bioresorbable coronary vascular scaffolds.
    Wang Y; van den Akker NM; Molin DG; Gagliardi M; van der Marel C; Lutz M; Knetsch ML; Koole LH
    Adv Healthc Mater; 2014 Feb; 3(2):290-9. PubMed ID: 23950056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials.
    Tanimoto S; Serruys PW; Thuesen L; Dudek D; de Bruyne B; Chevalier B; Ormiston JA
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):515-23. PubMed ID: 17503509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and future perspectives on drug-eluting bioresorbable coronary scaffolds.
    Ielasi A; Tespili M
    Future Cardiol; 2014 May; 10(3):409-20. PubMed ID: 24976477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future stent drug delivery systems.
    Caixeta A; Abizaid A; Aoki J; Dangas G; Mehran R
    Minerva Cardioangiol; 2008 Feb; 56(1):155-66. PubMed ID: 18432177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
    Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
    Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioresorbable Stents: Is This Where We Are Headed?
    Wayangankar SA; Ellis SG
    Prog Cardiovasc Dis; 2015; 58(3):342-55. PubMed ID: 26319497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational Bench Testing to Evaluate the Short-Term Mechanical Performance of a Polymeric Stent.
    Bobel AC; Petisco S; Sarasua JR; Wang W; McHugh PE
    Cardiovasc Eng Technol; 2015 Dec; 6(4):519-32. PubMed ID: 26577483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioresorbable stents: Current and upcoming bioresorbable technologies.
    Ang HY; Bulluck H; Wong P; Venkatraman SS; Huang Y; Foin N
    Int J Cardiol; 2017 Feb; 228():931-939. PubMed ID: 27912202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innovative DES technologies from Meril.
    Bhatt S; Gujarathi S; De Benedictis M
    Minerva Cardioangiol; 2015 Oct; 63(5):441-8. PubMed ID: 25921933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing vessel healing following drug eluting stent implantation with biodegradable polymer DES.
    Cerrato E; Echavarría-Pinto M; Tandjung K; Macaya C; Escaned J
    Minerva Cardioangiol; 2014 Oct; 62(5):407-20. PubMed ID: 25295492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioresorbable scaffolds for the treatment of coronary artery disease: current status and future perspective.
    Kraak RP; Grundeken MJ; Koch KT; de Winter RJ; Wykrzykowska JJ
    Expert Rev Med Devices; 2014 Sep; 11(5):467-80. PubMed ID: 25087771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting stent implantation for coronary artery disease: current stents and a comparison with bypass surgery.
    Head SJ; Bogers AJ; Kappetein AP
    Curr Opin Pharmacol; 2012 Apr; 12(2):147-54. PubMed ID: 22285216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.
    Costopoulos C; Latib A; Naganuma T; Miyazaki T; Sato K; Figini F; Sticchi A; Carlino M; Chieffo A; Montorfano M; Colombo A
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):E10-5. PubMed ID: 24909303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
    Stone GW; Ellis SG; Cannon L; Mann JT; Greenberg JD; Spriggs D; O'Shaughnessy CD; DeMaio S; Hall P; Popma JJ; Koglin J; Russell ME;
    JAMA; 2005 Sep; 294(10):1215-23. PubMed ID: 16160130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug-eluting metallic stent: Degradable meets durable.
    Wiebe J; Hamm C; Nef H
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1184-8. PubMed ID: 25581885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.